期 |
栏目 |
标题 |
文件 |
卷 83, 编号 4 (2011) |
Editorial |
B-cell lymphoma in a woman with chronic hepatitis C and mixed cryoglobulinemia of type 2 |
|
卷 83, 编号 11 (2011) |
Editorial |
Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia |
|
卷 87, 编号 6 (2015) |
Editorial |
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease |
|
卷 87, 编号 6 (2015) |
Editorial |
Cryoglobulinemic vasculitis with renal involvement: A historic aspect of the problem |
|
卷 88, 编号 6 (2016) |
Editorial |
Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection |
(Rus)
|
卷 89, 编号 5 (2017) |
Editorial |
Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment |
(Rus)
|
卷 90, 编号 6 (2018) |
Editorial |
Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration |
(Rus)
|
卷 90, 编号 6 (2018) |
Editorial |
Quality of life of chronic kidney disease patients on renal replacement therapy |
(Rus)
|
卷 90, 编号 6 (2018) |
Editorial |
HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems |
(Rus)
|
卷 91, 编号 11 (2019) |
Editorial |
Antiviral therapy of chronic hepatitis C: 30 years success story |
(Rus)
|